Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 04, 2026
Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08:00am, Thursday, 05'th Sep 2024
BRISBANE, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeut
SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference
08:00am, Thursday, 05'th Sep 2024
DENVER, Sept. 05, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of h
Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
07:30am, Thursday, 05'th Sep 2024
LOS ANGELES , Sept. 5, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on the development of high-purity, pathogen-
Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
07:03am, Thursday, 05'th Sep 2024
LOS ALTOS, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the �
ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
07:00am, Thursday, 05'th Sep 2024
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Sept. 05, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of therapeu
Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024
07:00am, Thursday, 05'th Sep 2024
CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announc
Global Digital Asset-Based Exchange Traded Products AUM Shows 69% YTD Growth, 3.8X Above Underlying Value
06:34am, Thursday, 05'th Sep 2024
London, United Kingdom--(Newsfile Corp. - September 5, 2024) - Fineqia International Inc. (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) (the "Company" or "Fineqia"), a leading digital asset and fintech in
Beam Global Closes Acquisition of Europe Based Telcom
06:00am, Thursday, 05'th Sep 2024
SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM) (“Beam Global” or the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the el
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Keyless Entry Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Keyless Entr
Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
05:22am, Thursday, 05'th Sep 2024
LUND, Sweden , Sept. 5, 2024 /PRNewswire/ -- Hansa Biopharma today announced that Søren Tulstrup will participate in a Fireside chat hosted by Douglas Tsao, Managing Director and Senior Financial Ana
TORONTO--(BUSINESS WIRE)---- $DMJ #carbonemissions--dynaCERT Inc. (TSX: DYA) (OTC: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce the September 2024 shipment of its proprietary
e.l.f. Expands Global Reach with Retail Launches and Market Growth
12:01am, Thursday, 05'th Sep 2024
OAKLAND, Calif.--(BUSINESS WIRE)--e.l.f. is expanding the reach of its unique value proposition, powerhouse innovation and disruptive marketing engine, driven by growth in existing non-U.S. markets an
Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
06:42pm, Wednesday, 04'th Sep 2024
HUNTSVILLE, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery
Coinbase to Continue Spending to Influence US and Global Policy
05:44pm, Wednesday, 04'th Sep 2024
Coinbase reportedly plans to continue its “elevated policy spend” through the U.S. presidential election and beyond. Beyond the U.S. election, the cryptocurrency exchange will continue its policy
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
05:13pm, Wednesday, 04'th Sep 2024
WASHINGTON , Sept. 4, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the H.C.
